Valeant tried and failed to get the medication approved in 2005 and then succeeded in 2006.In 2007, Valeant acquired the United Kingdom and European Union rights to market nabilone from Cambridge Laboratories.Nabilone was approved in Austria to treat chemotherapy-induced nausea in 2013; it was already approved in Spain for the same indication and was legal in Belgium to treat glaucoma, spasticity in multiple sclerosis, wasting due to AIDS, and chronic pain. See also
List of investigational analgesics


== References ==
Lupus vasculitis is a complication of systemic lupus erythematosus in which the autoimmune response causes the deposition of immune complexes, such as rheumatoid factor, within the blood vessels. It may manifest in as high as 56% of lupus patients throughout their life, in contrast to antiphospholipid syndrome which has a prevalence of 15%. Vasculitis more often affects younger men. == References ==